There are currently 29 clinical trials in Fayetteville, North Carolina looking for participants to engage in research studies. Trials are conducted at various facilities, including Cape Fear Valley Health System, Cumberland Research Associates, LLC, Carolina Institute for Clinical Research and Cumberland Research Associates. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
Recruiting
A 52-Week, Multi-center, Open-label, Active Treatment Extension Study to Evaluate Safety and Tolerability of Once Daily, Oral Administration of Resmetirom (MGL-3196)
Gender:
All
Ages:
18 years and above
Trial Updated:
11/28/2023
Locations: Cumberland Research Associates, Fayetteville, North Carolina
Conditions: Non-Alcoholic Fatty Liver Disease
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
Recruiting
Part 1 of the study determines the optimal dose of inupadenant to be given in combination with carboplatin and pemetrexed to patients that progressed after receiving specific first line treatments for Stage 3 or metastatic non-small cell lung cancer. Part 2 compares the efficacy of inupadenant to placebo when both are combined with carboplatin and pemetrexed for patients that progressed after receiving the same first line treatments for Stage 3 or metastatic non-small cell lung cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/20/2023
Locations: Carolina Institute for Clinical Research, Fayetteville, North Carolina
Conditions: Metastatic NSCLC, Stage III NSCLC
Comprehensive and Continuous Status Measurement of Pre- and Post-Deployment Warfighters With Mobile Application
Recruiting
In this study, we aim to continuously and comprehensively measure the mental and physical status of US Military Special Operation Forces (SOF) through a confidential and cybersecure research mobile application (app) over a six-month period. In conjunction with data collected via the mobile app, wearable sensors, such as the Apple Watch, will be used to continuously collect physiologic (e.g. heart rate) and other data (e.g. activity, sleep). Additionally, the app will have the capability of deliv... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/19/2023
Locations: Ft. Bragg, Fayetteville, North Carolina
Conditions: Military Operations, Military Activity
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Recruiting
The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.
Gender:
All
Ages:
Between 45 years and 84 years
Trial Updated:
04/04/2023
Locations: Cumberland Research Associates, Fayetteville, North Carolina
Conditions: Colorectal Cancer
STI/HIV Intervention Behavioral Intervention Program
Recruiting
The hypothesis is that a behavioral intervention tool adapted for the US military population will be acceptable and associated with a decrease in incident sexually transmitted infection (STI)/HIV rates and high-risk sexual behaviors, and increased self-reported condom use compared to the standard of care at the Joint Base Lewis-McChord (JBLM) Preventive Medicine clinic and the Fort Bragg Department of Public Health (part of Womack Army Medical Center).
Gender:
All
Ages:
Between 18 years and 30 years
Trial Updated:
01/20/2023
Locations: Ft. Bragg, Fayetteville, North Carolina
Conditions: Sexually Transmitted Infections